research-article

You have full text access to this OnlineOpen article

Placenta-Derived Multipotent Cells Exhibit Immunosuppressive Properties That Are Enhanced in the Presence of Interferon-γ

Chun-Jung Chang¹,
Men-Luh Yen²,
Yao-Chang Chen³,
Chih-Cheng Chien^4,5,
Hsing-I. Huang^4,6,
Chyi-Huey Bai⁷,
B. Linju Yen M.D.^1,*

Article first published online: 1 NOV 2006

DOI: 10.1634/stemcells.2006-0071

Issue

STEM CELLS

Volume 24, Issue 11, pages 2466–2477, November 2006

Additional Information

How to Cite

Chang, C.-J., Yen, M.-L., Chen, Y.-C., Chien, C.-C., Huang, H.-I., Bai, C.-H. and Yen, B. L. (2006), Placenta-Derived Multipotent Cells Exhibit Immunosuppressive Properties That Are Enhanced in the Presence of Interferon-γ. STEM CELLS, 24: 2466–2477. doi: 10.1634/stemcells.2006-0071

Author Information

¹
Stem Cell Research Center, National Health Research Institutes, Zhunan, Taiwan
²
Department of Primary Care Medicine and Department of Obstetrics/Gynecology, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan
³
Departments of Laboratory Medicine and Forensic Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan
⁴
Department of Medicine, School of Medicine, Fu Jen Catholic University, Taipei, Taiwan
⁵
Cathay General Hospital Neihu, Cathay General Hospital, Taipei, Taiwan
⁶
Cathay Medical Research Institute, Cathay General Hospital, Taipei, Taiwan
⁷
Central Laboratory, Shin Kong WHS Memorial Hospital, Taipei, Taiwan

Email: B. Linju Yen M.D. (blyen@nhri.org.tw)

^*Stem Cell Research Center, National Health Research Institutes, 35 Keyan Road, Zhunan, Miaoli County 350, Taiwan. Telephone: +886-2-2653-4401, ext. 27502; Fax: +886-2-2792-9679

Publication History

Issue published online: 2 JAN 2009
Article first published online: 1 NOV 2006
Manuscript Accepted: 14 JUL 2006
Manuscript Received: 3 FEB 2006

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (1042K)

References

1
Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282:1145–1147.
2
Reubinoff BE, Pera MF, Fong CY et al. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol 2000; 18:399–404.
3
Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143–147.
4
Koc ON, Gerson SL, Cooper BW et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18:307–316.
5
Chen SL, Fang WW, Ye F et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004; 94:92–95.
6
Mazzini L, Fagioli F, Boccaletti R et al. Stem cell therapy in amyotrophic lateral sclerosis: A methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4:158–161.
7
Koc ON, Day J, Nieder M et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30:215–222.
8
Lazarus HM, Koc ON, Devine SM et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005; 11:389–398.
9
Ringden O. Introduction to graft-versus-host disease. Biol Blood Marrow Transplant 2005;11 2 suppl 2 ():17–20.
10
Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30:42–48.
11
Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99:3838–3843.
12
Djouad F, Plence P, Bony C et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003; 102:3837–3844.
13
Krampera M, Glennie S, Dyson J et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101:3722–3729.
14
Tse WT, Pendleton JD, Beyer WM et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 2003; 75:389–397.
15
Glennie S, Soeiro I, Dyson PJ et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005; 105:2821–2827.
16
Beyth S, Borovsky Z, Mevorach D et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005; 105:2214–2219.
17
Le Blanc K, Rasmusson I, Gotherstrom C et al. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol 2004; 60:307–315.
Direct Link:
18
Krampera M, Cosmi L, Angeli R et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006; 24:386–398.
Direct Link:
19
Rasmusson I, Ringden O, Sundberg B et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003; 76:1208–1213.
20
Plumas J, Chaperot L, Richard MJ et al. Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia 2005; 19:1597–1604.
21
Augello A, Tasso R, Negrini SM et al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 2005; 35:1482–1490.
Direct Link:
22
Rao MS, Mattson MP. Stem cells and aging: Expanding the possibilities. Mech Ageing Dev 2001; 122:713–734.
23
Fukuchi Y, Nakajima H, Sugiyama D et al. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004; 22:649–658.
Direct Link:
24
In't Anker PS, Scherjon SA, Kleijburg-van der KC et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004; 22:1338–1345.
Direct Link:
25
Yen BL, Huang HI, Chien CC et al. Isolation of multipotent cells from human term placenta. Stem Cells 2005; 23:3–9.
Direct Link:
26
Wagner JE, Rosenthal J, Sweetman R et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88:795–802.
27
Miller JS, Tessmer-Tuck J, Pierson BA et al. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity. Biol Blood Marrow Transplant 1997; 3:34–44.
- PubMed,
- CAS
28
Lazar GA, Dang W, Karki S et al. Engineered antibody Fc variants with enhanced effector function. Proc Natl Acad Sci U S A 2006; 103:4005–4010.
29
Gehling UM, Ergun S, Schumacher U et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95:3106–3112.
30
Munn DH, Zhou M, Attwood JT et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281:1191–1193.
31
Hunt JS, Petroff MG, McIntire RH et al. HLA-G and immune tolerance in pregnancy. FASEB J 2005; 19:681–693.
32
Sakaguchi S, Sakaguchi N, Shimizu J et al. Immunologic tolerance maintained by CD25⁺ CD4⁺ regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182:18–32.
Direct Link:
33
Hori S, Nomura T, Sakaguchi S et al. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057–1061.
34
Korholz D, Kunst D, Hempel L et al. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19:691–695.
35
Dong H, Zhu G, Tamada K et al. B7–H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999; 5:1365–1369.
36
Freeman GJ, Long AJ, Iwai Y et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192:1027–1034.
37
Drukker M, Katchman H, Katz G et al. Human embryonic stem cells and their differentiated derivatives are less susceptible for immune rejection than adult cells. Stem Cells 2006; 24:221–229.
Direct Link:
38
Drukker M, Katz G, Urbach A et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A 2002; 99:9864–9869.
39
Li L, Baroja ML, Majumdar A et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 2004; 22:448–456.
Direct Link:
40
Gotherstrom C, Ringden O, Tammik C et al. Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 2004; 190:239–245.
41
Puissant B, Barreau C, Bourin P et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129:118–129.
Direct Link:
42
Meisel R, Zibert A, Laryea M et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004; 103:4619–4621.
43
Maccario R, Podesta M, Moretta A et al. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4⁺ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 2005; 90:516–525.
44
Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105:1815–1822.
45
Rifa'i M, Kawamoto Y, Nakashima I et al. Essential roles of CD8⁺CD122⁺ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 2004; 200:1123–1134.
46
Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245–252.
47
Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997; 9:10–16.
48
Jiang XX, Zhang Y, Liu B et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005; 105:4120–4126.
49
Zhang M, Tang H, Guo Z et al. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat Immunol 2004; 5:1124–1133.
50
Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363:1439–1441.

View Full Article with Supporting Information (HTML) Get PDF (1042K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Placenta-Derived Multipotent Cells Exhibit Immunosuppressive Properties That Are Enhanced in the Presence of Interferon-γ

STEM CELLS

How to Cite

Author Information

Publication History

ARTICLE TOOLS

References

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Placenta-Derived Multipotent Cells Exhibit Immunosuppressive Properties That Are Enhanced in the Presence of Interferon-γ

STEM CELLS

How to Cite

Author Information

Publication History

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

References

More content like this